What to Expect From Medtronic's Next Quarterly Earnings Report

Valued at a market cap of $126.4 billion, Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. The Galway, Ireland-based company is scheduled to announce its fiscal Q3 earnings for 2026 before the market opens on  Tuesday, Feb. 17.  

Ahead of this event, analysts expect this healthcare company to report a profit of $1.33 per share, down 4.3% from $1.39 per share in the year-ago quarter. The company has surpassed Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $1.36 per share in the previous quarter topped the consensus estimates by 3.8%.